Black Rock Inc. Amryt Pharma PLC Transaction History

Black Rock Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$6.8 - $8.01 $7,541 - $8,883	-1,109 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$6.3 - $10.86 $6,986 - $12,043	1,109 New	1,109 $9,000
Q4 2021 Feb 10, 2022	SELL	$9.44 - $12.24 $1,453 - $1,884	-154 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$9.63 - $12.47 $1,483 - $1,920	154 New	154 $2,000

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.